Welcome to our dedicated page for Simplify VettaFi Private Credit Stgy ETF news (Ticker: PCR), a resource for investors and traders seeking the latest updates and insights on Simplify VettaFi Private Credit Stgy ETF stock.
The Simplify VettaFi Private Credit Strategy ETF (PCR) generates news that centers on its role as an exchange-traded fund providing private credit exposure with an integrated credit hedge. Announcements from Simplify Asset Management highlight both the fund’s launch and subsequent updates that are relevant to investors tracking private credit strategies and ETF structures.
One key category of news for PCR involves strategy and index design. At launch, Simplify described PCR’s objective of seeking to track the returns of the VettaFi Private Credit Index, which is based on a universe of Business Development Companies (BDCs) and publicly traded Closed-End Funds (CEFs) primarily engaged in private credit. News in this area can include details on how potential index constituents are screened for market capitalization, liquidity, volatility, and dividend yield.
Another important stream of updates relates to risk management and hedging. PCR employs a proprietary credit hedge that goes long stocks with high-quality metrics and short stocks with low-quality metrics, and communications about the fund explain how this hedge is intended to interact with credit spreads and credit events. These disclosures are of interest to investors who follow developments in credit markets and factor-based hedging approaches.
In addition, PCR has been the subject of valuation and operations news, such as the announcement of restated net asset values (NAVs) for a defined period due to incorrect swaps financing rates. Such notices provide transparency into how derivatives and financing assumptions affect ETF NAVs and may be closely watched by investors who monitor operational accuracy and fund governance.
By following PCR-related news, readers can review updates on its private credit exposure, hedging approach, and operational disclosures. This page consolidates press releases and other coverage so that investors and observers can revisit the fund’s launch information, risk discussions, and any subsequent corrections or clarifications in one place.
Simplify Asset Management restated the net asset values (NAVs) per share for three ETFs effective March 6, 2026. Revised NAVs cover February 27 to March 3, 2026: PCR (revised 19.90 from 20.01 on 2/27; 20.11 from 20.25 on 3/2), PFIX (43.93 from 43.35 on 3/3) and RFIX (43.00 from 42.19 on 3/3).
The company attributed the adjustments to an incorrect dividend for PCR and swaption forward premium errors for PFIX and RFIX.
Simplify VettaFi Private Credit Strategy ETF (NYSE Arca: PCR) restated net asset values for shares dated January 20–26, 2026, effective January 30, 2026. Revised NAVs rose about 2.02%–2.04% for 1/20–1/23 and increased 0.13% on 1/26. The firm attributed adjustments to missed dividends posting.
Simplify Asset Management announced a NAV restatement for the Simplify VettaFi Private Credit Strategy ETF (NYSE Arca: PCR) effective December 24, 2025.
The fund revised daily NAVs for September 25 to November 11, 2025, with adjustments ranging from -0.02% to -0.81%. The largest single-day downward adjustment was on November 11, 2025 (-0.81%).
The company attributed the revisions to incorrect swaps financing rates used in prior NAV calculations and provided the revised and original NAVs for each affected date.
Simplify Asset Management has launched the Simplify VettaFi Private Credit Strategy ETF (PCR), a new ETF designed to provide investors with private credit exposure through BDCs and publicly traded closed-end funds, combined with a built-in credit hedging strategy.
The fund tracks the VettaFi Private Credit Index and employs a proprietary hedging strategy that goes long on high-quality stocks while shorting low-quality stocks. This hedge is designed to have a positive correlation with credit spreads and includes a historical positive carry.
PCR aims to make private credit investing more accessible by addressing common barriers such as high fees, complex tax reporting, and limited liquidity, while offering potential income generation and portfolio diversification benefits.